These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 3491151

  • 21. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR, Renauld JC, Houssiau FA.
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [Abstract] [Full Text] [Related]

  • 22. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
    Lebow LT, Jewett A, Bonavida B.
    J Immunol; 1993 Jan 01; 150(1):320-9. PubMed ID: 8417130
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
    McCrady CW, Li F, Grant AJ, Merchant RE, Carchman RA.
    Cancer Res; 1988 Feb 01; 48(3):635-40. PubMed ID: 3257170
    [Abstract] [Full Text] [Related]

  • 25. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G.
    Cell Immunol; 1994 Jul 01; 156(2):480-92. PubMed ID: 7912999
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
    Itoh K, Tilden AB, Kumagai K, Balch CM.
    J Immunol; 1985 Feb 01; 134(2):802-7. PubMed ID: 3917475
    [Abstract] [Full Text] [Related]

  • 29. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
    Nagler A, Lanier LL, Phillips JH.
    J Immunol; 1988 Oct 01; 141(7):2349-51. PubMed ID: 3262658
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The majority of immature fetal thymocytes can be induced to proliferate to IL-2 and differentiate into cells indistinguishable from mature natural killer cells.
    Brooks CG, Georgiou A, Jordan RK.
    J Immunol; 1993 Dec 15; 151(12):6645-56. PubMed ID: 8258682
    [Abstract] [Full Text] [Related]

  • 32. Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.
    Thurman GB, Maluish AE, Rossio JL, Schlick E, Onozaki K, Talmadge JE, Procopio AD, Ortaldo JR, Ruscetti FW, Stevenson HC.
    J Biol Response Mod; 1986 Feb 15; 5(1):85-107. PubMed ID: 3514800
    [Abstract] [Full Text] [Related]

  • 33. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul 15; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 34. Differential activity of recombinant lymphokines on mouse B cell proliferation and cell cycle progression are revealed by 5-bromo-2'-deoxyuridine/Hoechst 33258 dye flow cytometry.
    Seyschab H, Hoehn H, Rabinovitch PS, Chen U.
    Eur J Immunol; 1991 Sep 15; 21(9):2153-60. PubMed ID: 1909644
    [Abstract] [Full Text] [Related]

  • 35. Comparison of natural killer activity of human bone marrow and blood cells in cultures containing IL-2, IL-7 and IL-12.
    Wong EK, Eaves C, Klingemann HG.
    Bone Marrow Transplant; 1996 Jul 15; 18(1):63-71. PubMed ID: 8831997
    [Abstract] [Full Text] [Related]

  • 36. Thy-1+ epidermal cells proliferate in response to concanavalin A and interleukin 2.
    Nixon-Fulton JL, Bergstresser PR, Tigelaar RE.
    J Immunol; 1986 Apr 15; 136(8):2776-86. PubMed ID: 2870120
    [Abstract] [Full Text] [Related]

  • 37. T cell sensitivity to HLA class I-mediated apoptosis is dependent on interleukin-2 and interleukin-4.
    Genestier L, Paillot R, Bonnefoy-Berard N, Waldmann H, Revillard JP.
    Eur J Immunol; 1997 Feb 15; 27(2):495-9. PubMed ID: 9045922
    [Abstract] [Full Text] [Related]

  • 38. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H, Ueno Y, Taga K, Matsuda A, Miyawaki T, Taniguchi N.
    J Immunol; 1985 Oct 15; 135(4):2351-6. PubMed ID: 3928745
    [Abstract] [Full Text] [Related]

  • 39. MAC technique (morphology antibody chromosomes) in phenotypic identification of proliferating NK and T cells in interleukin-2-stimulated lymphocyte cultures.
    Kovanen PE, Timonen T, Seppälä I, Knuutila S.
    Clin Exp Immunol; 1989 Mar 15; 75(3):407-13. PubMed ID: 2649292
    [Abstract] [Full Text] [Related]

  • 40. A novel epitope of N-CAM defines precursors of human adherent NK cells.
    Li S, Xu J, Makarenkova VP, Tjandrawan T, Vakkila J, Reichert T, Gooding W, Lagenaur CF, Achim CL, Chambers WH, Herberman RB, Whiteside TL, Vujanovic NL.
    J Leukoc Biol; 2004 Dec 15; 76(6):1187-99. PubMed ID: 15356097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.